What does the research say about Black Cumin?
22 health outcomes synthesisedBlack Cumin (Nigella sativa) has been studied for 22 health outcomes, with the strongest evidence supporting its effects on blood sugar control, blood pressure, and body weight. The most robust research area involves fasting blood glucose, where 7 of 8 studies reported beneficial effects, including meta-analyses with over 5,000 participants. Doses in these studies ranged from 200 to 4,600 mg/day, and effects were observed primarily in adults with type 2 diabetes, metabolic syndrome, or cardiovascular conditions.
Strongest evidence
- Blood glucose and HbA1c: High-strength evidence from 8 studies on fasting blood glucose (7 beneficial) and 6 studies on HbA1c (5 beneficial) shows moderate-to-large reductions. Doses ranged from 200 to 4,600 mg/day, with median study durations of 32 days (glucose) and 7 days (HbA1c).
- Body weight and BMI: High evidence for weight loss (5 of 7 studies beneficial, small effect size) and moderate evidence for BMI reduction (4 of 6 studies beneficial). Meta-analyses report weight reductions of about -1.6 kg and BMI reductions of -0.5 to -0.7 kg/m², typically at doses of 400–4,600 mg/day over 8 weeks.
- Blood pressure: All 5 studies on systolic and diastolic blood pressure showed beneficial effects (high evidence), with small reductions (~3 mmHg systolic) and mixed effect sizes for diastolic. Effects were observed in patients with metabolic or cardiovascular conditions at 8 weeks.
Mixed or weaker evidence
- Inflammation markers: Moderate evidence for reductions in IL-6 (4 of 4 studies beneficial) and TNF-α (4 of 4 beneficial), with moderate effect sizes. Doses of 2,000–4,600 mg/day were used, but study durations were short (median 7 days for TNF-α).
- Cholesterol and LDL: All 4 studies on total cholesterol showed beneficial effects (moderate-to-large), but one meta-analysis in type 2 diabetes found no significant LDL reduction, indicating possible population-specific effects. LDL evidence is moderate, with 3 of 4 studies beneficial.
- Insulin sensitivity: All 4 studies reported improvements (small-to-moderate effect), but study durations were very short (only 7 days reported), and dose ranges were broad.
- Waist circumference: Only 3 studies, with 2 beneficial and 1 neutral (in adolescents with PCOS), providing moderate evidence. Effects were small-to-moderate.
Effective dose patterns
- A consistent dose range of 200–4,600 mg/day appears across multiple outcomes, but many studies did not specify the exact dose or form (oil vs. powder). The most common reported durations were 32–56 days for blood glucose and weight outcomes, and as short as 7 days for HbA1c and inflammation markers.
Population insights
- The majority of research focuses on clinical populations: adults with type 2 diabetes, metabolic syndrome, coronary artery disease, or postmenopausal women with hypertension. Effects in healthy individuals are less studied, and neutral results were noted in adolescents with PCOS for weight and waist circumference, suggesting benefits may not be universal.
Notable caveats
- Publication bias is a concern across all outcomes—null-result studies are less likely to be published.
- Most studies did not report the supplement form (e.g., oil, powder, extract), making it unclear which preparation is most effective.
- Median study durations are often short (≤8 weeks), and long-term effects are unknown.
- Heterogeneity in effect sizes (small to large) across studies likely reflects differences in populations, dosages, and study designs.
Frequently asked
What is Black Cumin good for according to research?
Research shows Black Cumin (Nigella sativa) may help reduce fasting blood glucose, HbA1c, body weight, BMI, and blood pressure, based on high-strength evidence from multiple meta-analyses. Moderate evidence also supports reductions in inflammation markers (IL-6, TNF-α) and improvements in cholesterol and insulin sensitivity. The strongest evidence is for blood sugar control, with 7 of 8 studies showing beneficial effects on fasting glucose.
What dose of Black Cumin is typically used in studies?
Doses in clinical studies range broadly from 200 to 4,600 mg per day, with many studies not specifying a precise dose. The most common ranges appear to be 400–4,600 mg per day for weight and blood pressure outcomes, and 2,000–4,600 mg per day for inflammation markers. Study durations are typically 4–8 weeks, though some studies lasted only 7 days.
Who benefits most from Black Cumin?
The strongest evidence comes from studies in adults with type 2 diabetes, metabolic syndrome, coronary artery disease, and postmenopausal women with hypertension. Effects on weight and waist circumference were not observed in a small study of adolescents with PCOS, suggesting benefits may be more consistent in middle-aged and older adults with metabolic or cardiovascular conditions.
Are there caveats or limitations in the research on Black Cumin?
Yes. Publication bias is a concern across all outcomes—null results are less likely to be published. Most studies did not report the form of Black Cumin used (oil, powder, etc.), making it unclear which preparation is most effective. Study durations are often short (≤8 weeks), and long-term effects are unknown. Effect sizes vary widely, and many trials lack adequate data on dosing and population characteristics.
Does Black Cumin help with blood sugar control?
Yes, high-strength evidence from 8 studies (7 beneficial) shows Black Cumin reduces fasting blood glucose, with moderate-to-large effect sizes. Similarly, 5 of 6 studies found reductions in HbA1c (moderate effect). The most robust evidence comes from meta-analyses including over 5,000 participants, primarily in adults with type 2 diabetes or metabolic syndrome, at doses of 200–4,600 mg/day.
Does Black Cumin lower blood pressure?
All 5 studies on systolic and diastolic blood pressure reported beneficial effects (high evidence), with small reductions in systolic blood pressure (about -3 mmHg) and mixed effect sizes for diastolic. Effects were observed at 8 weeks in patients with metabolic diseases, coronary artery disease, or postmenopausal hypertension. Doses ranged from 400 to 4,600 mg/day, but no specific dose was consistently identified as optimal.
Safety profile
6 studies reporting safety data
Across 6 clinical studies, no specific adverse events were quantitatively reported and no serious adverse events were flagged. Black Cumin was generally described as well tolerated, with one study noting nausea as a common adverse effect (7.04% incidence). Overall, the available safety profile suggests good tolerability in the studied populations.
Caveats: The evidence base is limited to 6 studies, and most trials may have been of short duration; long-term safety is not established. Findings are based on specific formulations and populations; safety in other groups (e.g., pregnant women, children) is not characterized. Studies were likely not powered for safety, so rare adverse events may not have been detected.